stocktitan.netSEP 91 min read$AMBQ

Ambiq Micro (AMBQ) director exercises options and sells shares

Ambiq Micro (AMBQ) director Ker Zhang exercised options for 1,785 shares at $5.88 each on September 4, 2026, and sold 185 shares at $56.92 per share. The option was fully exercised with no remaining balance. No Rule 10b5-1 trading plan was reported.

Original reporting

stocktitan.net

Published Sep 9, 2026, 9:08 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Sep 10, 2026, 1:08 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefFinancial news

Primary signal

$AMBQ

Neutral

high confidence

Mentioned

$AMBQ

Relevance

4/10

AlphAI data visualization · based on stocktitan.net

Decision brief

The 30-second read

$AMBQNeutralLow

Why it matters

The disclosed sale is small and does not suggest a material shift in insider confidence.

Market read

Limited relevance; primarily of interest to existing shareholders and micro‑cap traders.

What to watch

Potential upcoming product milestones or financing needs not disclosed.

Relevance 4/10Novelty 2/10Timing: Sep 4 2026 (same‑day filing)

Background

Ambiq Micro (NASDAQ: AMBQ) is a low‑power AI chip maker. The filing reports a routine insider option exercise and sale.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$AMBQNeutralHigh confidence

Context

Director Ker Zhang exercised 1,785 options at $5.88 and sold 185 shares at $56.92 on Sep 4, 2026.

Expected impact

Minimal impact; price likely unchanged.

Evidence & confidence

The transaction size (~$11k) is trivial for a public company and no 10b5‑1 plan was used.

Market effects

Sector

None; insider activity does not affect the broader semiconductor sector.

Regional

None; limited to Ambiq Micro shareholders.

Global

None; the trade is micro‑cap specific.

Counterpoint

What could challenge this read

If the director is reducing exposure, it could hint at concerns about near‑term valuation.

Key entities

Director
Ker Zhang
Ambiq Micro director who exercised and sold shares.

Read at source ← All news

AUG 13

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

yahoo.com4 min

AUG 12

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

businesstimes.com.sg3 min

AUG 12

$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.

fool.com6 min

AUG 11

$AMBQHigh

Ambiq Micro, Inc. (AMBQ): Results of Operations and Financial Condition

Ambiq Micro, Inc. (AMBQ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Ambiq Reports Second Quarter 2026 Financial Results Delivered record quarterly net sales, increasing approximately 90% year-over-year, driven by strong demand for edge AI solutions Gross profit more than doubled year-over-year on higher net sales and margin expansion Expect third

SEC EDGAR 8-K6 min

SEP 26

$MSFTMed

Wall Street ends higher on AI stocks buying

Wall Street rose on Friday, led by AI-related stocks like Microsoft (+3.7%), Qualcomm (+4%), and Dell (+5%). Akamai (+3.2%) gained after an $11.6B deal with Anthropic. Meta fell 3.3% despite a 13% weekly gain. S&P 500 (+0.51%), Nasdaq (+0.48%), and Dow (+0.93%) all closed higher.

tribune.com.pk2 min